Artigo - Atena Editora

Artigo

Baixe agora

Livros

DRUG THERAPIES FOR OBESITY IN ADULTS

Objective: Evaluate the basis for the emergence of obesity and the pharmacological possibilities available on the market for its treatment. Methods: An integrative review was carried out, using as criteria the search in the National Library of Medicine (PubMed) and Scientific Electronic Library Online (SciELO) databases using the descriptors (i) obesity (ii)Antiobesity Drugs, (iii) adults with the Boolean operator “AND”. Studies published from 2020 to 2024 were included. Results: Obesity is a chronic disease that goes beyond being overweight and is increasing in global prevalence, develops from a chronic and positive energy balance, under the influence of multiple factors of social, behavioral and environmental origin with the formation of an obesogenic environment. At the end of all the discussion it is clear that there are several therapy options for obesity on the market, which have their advantages and disadvantages and it is up to the medical professional together with the patient to opt for the therapy that best suits the patient's profile so that they You can not only lose weight, but also keep it off over the years. Conclusion: It is concluded that, according to studies, multidisciplinary therapy is necessary in order to understand associated hereditary and environmental factors. It must also be highlighted that although drug therapies and surgical interventions, such as bariatric surgery, control obesity and alleviate its comorbidities, they do not solve the problem as the disease causes several changes in the body that must be addressed in the long term, aiming to an improved quality of life.

Ler mais

DRUG THERAPIES FOR OBESITY IN ADULTS

  • DOI: https://doi.org/10.22533/at.ed.15945524140611

  • Palavras-chave: Obesity, anti-obesity and adult drugs.

  • Keywords: Obesity, anti-obesity and adult drugs.

  • Abstract:

    Objective: Evaluate the basis for the emergence of obesity and the pharmacological possibilities available on the market for its treatment. Methods: An integrative review was carried out, using as criteria the search in the National Library of Medicine (PubMed) and Scientific Electronic Library Online (SciELO) databases using the descriptors (i) obesity (ii)Antiobesity Drugs, (iii) adults with the Boolean operator “AND”. Studies published from 2020 to 2024 were included. Results: Obesity is a chronic disease that goes beyond being overweight and is increasing in global prevalence, develops from a chronic and positive energy balance, under the influence of multiple factors of social, behavioral and environmental origin with the formation of an obesogenic environment. At the end of all the discussion it is clear that there are several therapy options for obesity on the market, which have their advantages and disadvantages and it is up to the medical professional together with the patient to opt for the therapy that best suits the patient's profile so that they You can not only lose weight, but also keep it off over the years. Conclusion: It is concluded that, according to studies, multidisciplinary therapy is necessary in order to understand associated hereditary and environmental factors. It must also be highlighted that although drug therapies and surgical interventions, such as bariatric surgery, control obesity and alleviate its comorbidities, they do not solve the problem as the disease causes several changes in the body that must be addressed in the long term, aiming to an improved quality of life.

  • Amanda Lima Souza
  • Caiohan Dalfiôr
  • Gustavo Vasconcelos Ribeiro
  • Thállita Gabriela Freitas Ferreira
  • Gustavo André Tabalipa
  • Taisnara Martins Oliveira
  • Victória Flávia Vieira Rodrigues
  • Roosevelt Regis Amorim
  • Elaine Aparecida Lazaroni Baita
  • Vivianne Galante Ramos
  • Emanuela Dias Dotto BrevesEmanuela Dias Dotto Breves
Fale conosco Whatsapp